−10.3
Newron Pharmaceuticals SpA
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions EUR
FY21:
FY22:
−15.6
FY23:
−10.1
FY24:
−17.6
FY25:
32.3
Change from FY21 to FY25
millions EUR
FY21:
8.42
FY22:
−0.32
FY23:
3.26
FY24:
3.17
FY25:
−13.6
Change from FY21 to FY25
millions EUR
FY21:
15.0
FY22:
0
FY23:
0
FY24:
15.4
FY25:
−26.8
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−11.5
FY22:
−11.1
FY23:
−10.2
FY24:
−17.6
FY25:
32.3
All amounts in millions EUR